![Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease | Science Advances Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease | Science Advances](https://www.science.org/cms/10.1126/sciadv.aav0316/asset/785a1f26-bc7a-4da4-bb85-b638a5441d7c/assets/graphic/aav0316-f1.jpeg)
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease | Science Advances
![A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties - ScienceDirect A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523420307376-fx1.jpg)
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties - ScienceDirect
![Some novel MAO inhibitor agents and reference model of target compounds. | Download Scientific Diagram Some novel MAO inhibitor agents and reference model of target compounds. | Download Scientific Diagram](https://www.researchgate.net/publication/355879106/figure/fig2/AS:1086062571065347@1635948903698/Some-novel-MAO-inhibitor-agents-and-reference-model-of-target-compounds_Q320.jpg)
Some novel MAO inhibitor agents and reference model of target compounds. | Download Scientific Diagram
![Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis | Experimental & Molecular Medicine Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis | Experimental & Molecular Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs12276-021-00646-3/MediaObjects/12276_2021_646_Fig5_HTML.png)
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis | Experimental & Molecular Medicine
![Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones - Singh - 2023 - Chemical Biology & Drug Design - Wiley Online Library Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones - Singh - 2023 - Chemical Biology & Drug Design - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9ba066d7-203a-4a3e-9f9e-3139a818edfc/cbdd14238-fig-0001-m.jpg)
Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones - Singh - 2023 - Chemical Biology & Drug Design - Wiley Online Library
![A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson's disease A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson's disease](https://oaepublishstorage.blob.core.windows.net/41ce4104-708d-4051-a282-4a546ae13dde/4503.fig.1.jpg)
A novel neuroprotective cholinesterase-monoamine oxidase inhibitor for treatment of dementia and depression in Parkinson's disease
![Molecules | Free Full-Text | Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders Molecules | Free Full-Text | Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders](https://pub.mdpi-res.com/molecules/molecules-24-00418/article_deploy/html/images/molecules-24-00418-ag-550.jpg?1570993104)